Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-31 @ 10:55 PM
Study NCT ID:
NCT03359460
Status:
COMPLETED
Last Update Posted:
2021-10-19
First Post:
2017-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
Sponsor:
Brian Jonas
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-27
First Submit QC Date:
None
Study First Post Date:
2017-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-11
Last Update Post Date:
2021-10-19
Last Update Post Date Type:
ACTUAL